N. Radojevic et al., Characterization of enteric functional changes evoked by in vivo anti-CD3 T cell activation, AM J P-REG, 45(3), 1999, pp. R715-R723
Citations number
41
Categorie Soggetti
Physiology
Journal title
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
Specific in vivo T cell activation initiated by treatment with anti-CD3 ant
ibodies leads to diarrhea and structural damage of the intestinal mucosa. I
n this study, the effect of T cell-induced mucosal damage on jejunal epithe
lial ion transport, muscle contractility, and neuronal ACh release was asse
ssed in Ussing chambers, organ baths, and a specialized perfusion apparatus
, respectively. Time-matched control mice received hamster serum containing
irrelevant antibodies. Jejunal segments from anti-CD3-treated mice display
ed a significantly elevated epithelial baseline short-circuit current (whic
h indicates increased ion transport) and a concomitant reduction in respons
iveness to prosecretory stimuli (nerve stimulation, carbachol, and forskoli
n). Longitudinal smooth muscle displayed altered spontaneous contractile ac
tivity, length-tension relationships, and carbachol-stimulated contraction
in tissues excised from mice 20 and 40 h posttreatment. Anti-CD3 treatment
did not affect stimulated ACh release from myenteric plexus neurons. We con
clude that specific T cell activation via anti-CD3 antibody results in dram
atic alterations in jejunal epithelial and smooth muscle function. Such T c
ell-induced changes in intestinal function may contribute to the symptomato
logy of T cell-mediated enteropathies, including graft-versus-host disease,
celiac disease, and idiopathic inflammatory bowel disease.